Cassava Sciences Inc. sell stratec
Start price
27.06.18
/
50%
€1.95
Target price
02.07.18
€1.53
Performance (%)
-4.63%
End price
02.07.18
€1.86
Summary
This prediction ended on 02.07.18 with a price of €1.86. With a performance of -4.63%, the SELL prediction for Cassava Sciences Inc. by stratec was down slightly. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cassava Sciences Inc. | -5.670% | -5.670% | 16.784% | -93.296% |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % | 45,72 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % | 73,26 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % | 48,77 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % | 55,80 % |
Comments by stratec for this prediction
In the thread Cassava Sciences Inc. diskutieren
stratec stimmt dem Sentiment von 'Buy' nicht zu
stratec stimmt am 27.06.2018 dem Buy-Gesamtsentiment mit dem Kursziel 9.0$ nicht zu.
- A joint FDA panel has voted against approval for Pain Therapeutics Remoxy ER treatment.
(Vom Mitglied beendet)